Davids MS, Ambrose J, de Nigris E, Prescott J, Leng S, Yang J, Zettler CM, Fernandes LL, Wang C-K, Barr PM. Real-world treatment patterns and outcomes in patients with chronic lymphocytic leukemia previously exposed to both covalent Bruton’s tyrosine kinase inhibitor and B-cell lymphoma 2 inhibitor therapy. haematol [Internet]. 2020Sep.10 [cited 2026Oct.13];. Available from: https://haematologica.org/article/view/14467